Sunday August 9, 2020 08:55

Heathcare Press Release : 24 Jul 2020

Menarini Group and Radius Health Announce Global License Agreement for the Development and Heathcare—24 Jul 20

- Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development - Elacestrant further strengthens Menarini's global oncology portfolio, recently bolstered by the acquisition of